Next Quarterly Earnings
Thursday, November 12, 2026
CW 46
Pre-Market
In 77 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
CG Oncology
CG Oncology is a US-based biotechnology company specializing in the development of innovative oncolytic immunotherapies. The company focuses on combating bladder cancer through targeted therapeutic solutions, aiming to sustainably improve treatment outcomes for cancer patients.
Frequently asked questions
When will CG Oncology report its next quarterly earnings?
CG Oncology is scheduled to report its next quarterly earnings on 11/12/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did CG Oncology last report quarterly earnings?
CG Oncology last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.90 USD.
How does CG Oncology stock react to earnings?
Across its last 3 earnings reports, CG Oncology stock moved by ±2.9% on average the following day. The largest reaction was +4.8% on 02/27/2026; 3 of 3 reactions were positive.
How often has CG Oncology beaten expectations?
CG Oncology has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
How do I add the CG Oncology earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±2.9%
Avg. next-day move
+4.8%
Largest move (02/27/2026)
100%
Share of positive reactions
±5.6%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
1/5
Quarters above estimates
20%
Beat rate
-11%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
CG Oncology
Country
🇺🇸
More Financial Information